• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PD-1/PD-L1 表达在葡萄膜黑色素瘤中的预后意义:与肿瘤浸润淋巴细胞和临床病理参数的相关性。

Prognostic significance of PD-1/PD-L1 expression in uveal melanoma: correlation with tumor-infiltrating lymphocytes and clinicopathological parameters.

机构信息

Department of Ocular Pathology, Dr. R P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Department of Ophthalmology, Gavin Herbert Eye Institute, University of California, Irvine, USA.

出版信息

Cancer Immunol Immunother. 2021 May;70(5):1291-1303. doi: 10.1007/s00262-020-02773-8. Epub 2020 Nov 2.

DOI:10.1007/s00262-020-02773-8
PMID:33136179
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10991427/
Abstract

BACKGROUND

To understand how to improve the effect of immune checkpoint inhibitors in uveal melanoma (UM), we need a better understanding of the expression of PD-1 and PD-L1, their relation with the presence of tumor-infiltrating lymphocytes (TILs), and their prognostic relevance in UM patients.

MATERIALS AND METHODS

Expression of PD-1 and PD-L1 was assessed in 71 UM tissue samples by immunohistochemistry and quantitative real-time PCR (qRT-PCR), and further validated by western blotting. The effect of interferon gamma (IFN-γ) on PD-1/PD-L1 expression was determined on four UM cell lines.

RESULTS

Immunoreactivity of PD-1 was found in 30/71 cases and of PD-L1 in 44/71 UM samples. Tumor-infiltrating lymphocytes were found in 46% of UM tissues. PD-1 was expressed on TILs while tumor cells expressed PD-L1. UM with and without TILs showed expression of PD-1 in 69% and 18% cases, respectively (p = 0.001). Similarly, PD-L1 was found in 75% of UM with TILs and in 50% of cases without TILs, respectively (p = 0.03). DFS rate were lower in patients with TILs with expression of PD-1 and PD-L1, but the rate of DFS was higher with expression of PD-L1 in patients without TILs. After treatment of UM cell lines with IFN-γ, PD-1 expression was induced in all UM cell lines whereas PD-L1 expression was found at a lower level in untreated cells, while expression also increased following treatment with IFN-γ.

CONCLUSION

Our study suggests that increased infiltration with TILs promotes the aggressive behavior and suppresses the immune response of UM cells, thereby inhibiting immunotherapy.

摘要

背景

为了了解如何提高免疫检查点抑制剂在葡萄膜黑色素瘤(UM)中的疗效,我们需要更好地了解 PD-1 和 PD-L1 的表达、它们与肿瘤浸润淋巴细胞(TILs)的存在的关系,以及它们在 UM 患者中的预后相关性。

材料和方法

通过免疫组织化学和实时定量 PCR(qRT-PCR)评估了 71 例 UM 组织样本中 PD-1 和 PD-L1 的表达,并通过 Western blot 进一步验证。测定干扰素γ(IFN-γ)对四种 UM 细胞系中 PD-1/PD-L1 表达的影响。

结果

在 71 例 UM 样本中,有 30 例检测到 PD-1 免疫反应性,44 例检测到 PD-L1 免疫反应性。在 46%的 UM 组织中发现了肿瘤浸润淋巴细胞。TILs 表达 PD-1,而肿瘤细胞表达 PD-L1。有和没有 TILs 的 UM 分别有 69%和 18%的病例表达 PD-1(p=0.001)。同样,有 TILs 的 UM 中有 75%和没有 TILs 的 UM 中有 50%分别发现 PD-L1 的表达(p=0.03)。在有 TILs 表达 PD-1 和 PD-L1 的患者中,DFS 率较低,但在没有 TILs 表达 PD-L1 的患者中,DFS 率较高。用 IFN-γ处理 UM 细胞系后,所有 UM 细胞系中均诱导表达 PD-1,而未经处理的细胞中 PD-L1 表达水平较低,用 IFN-γ处理后表达也增加。

结论

我们的研究表明,TILs 的浸润增加促进了 UM 细胞的侵袭行为并抑制了免疫反应,从而抑制了免疫治疗。

相似文献

1
Prognostic significance of PD-1/PD-L1 expression in uveal melanoma: correlation with tumor-infiltrating lymphocytes and clinicopathological parameters.PD-1/PD-L1 表达在葡萄膜黑色素瘤中的预后意义:与肿瘤浸润淋巴细胞和临床病理参数的相关性。
Cancer Immunol Immunother. 2021 May;70(5):1291-1303. doi: 10.1007/s00262-020-02773-8. Epub 2020 Nov 2.
2
Implications of LAG3 and CTLA4 immune checkpoints beyond PD-1/PD-L1 as a potential target in determining the prognosis of uveal melanoma patients.LAG3 和 CTLA4 免疫检查点除 PD-1/PD-L1 以外作为预测葡萄膜黑色素瘤患者预后的潜在靶点的意义。
Br J Ophthalmol. 2024 May 21;108(6):903-912. doi: 10.1136/bjo-2022-322913.
3
Programmed cell death ligand-1 expression in tumor and immune cells is associated with better patient outcome and decreased tumor-infiltrating lymphocytes in uveal melanoma.肿瘤细胞和免疫细胞程序性死亡配体 1 的表达与葡萄膜黑色素瘤患者更好的预后相关,并与肿瘤浸润淋巴细胞减少相关。
Mod Pathol. 2018 Aug;31(8):1201-1210. doi: 10.1038/s41379-018-0043-5. Epub 2018 Mar 26.
4
Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC).程序性死亡配体-1和CD8肿瘤浸润淋巴细胞(TILs)作为高级别浆液性卵巢癌(HGSC)的预后预测指标
J Egypt Natl Canc Inst. 2021 Jul 9;33(1):16. doi: 10.1186/s43046-021-00073-5.
5
The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.在炎性乳腺癌中,同时存在 CD20+B 细胞和 PD-L1+肿瘤浸润淋巴细胞与患者预后改善相关。
Breast Cancer Res Treat. 2018 Sep;171(2):273-282. doi: 10.1007/s10549-018-4834-7. Epub 2018 Jun 1.
6
Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.程序性细胞死亡蛋白1(PD-1)和PD-配体1(PD-L1)在大肠癌细胞及肿瘤浸润淋巴细胞中的表达对结直肠癌的预后影响
Mol Cancer. 2016 Aug 24;15(1):55. doi: 10.1186/s12943-016-0539-x.
7
LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes.LAG-3 蛋白在非小细胞肺癌中的表达及其与 PD-1/PD-L1 和肿瘤浸润淋巴细胞的关系。
J Thorac Oncol. 2017 May;12(5):814-823. doi: 10.1016/j.jtho.2017.01.019. Epub 2017 Jan 26.
8
PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating Lymphocytes.非小细胞肺癌中PD-1、PD-L1蛋白表达及其与肿瘤浸润淋巴细胞的关系
Med Sci Monit. 2017 Mar 9;23:1208-1216. doi: 10.12659/msm.899909.
9
The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC).免疫检查点抑制剂的治疗候选物由三阴性乳腺癌(TNBC)中肿瘤浸润淋巴细胞(TILs)和程序性死亡配体 1(PD-L1)表达的状态所阐明。
Breast Cancer. 2018 Jan;25(1):34-42. doi: 10.1007/s12282-017-0781-0. Epub 2017 May 9.
10
Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.程序性死亡受体 1/程序性死亡配体 1 通路在胃神经内分泌癌中的临床意义。
World J Gastroenterol. 2019 Apr 14;25(14):1684-1696. doi: 10.3748/wjg.v25.i14.1684.

引用本文的文献

1
Integrating pathomics and deep learning for subtyping uveal melanoma: identifying high-risk immune infiltration profiles.整合病理组学和深度学习用于葡萄膜黑色素瘤的亚型分类:识别高危免疫浸润特征。
Front Immunol. 2025 Jul 9;16:1585097. doi: 10.3389/fimmu.2025.1585097. eCollection 2025.
2
NAD Metabolism Reprogramming Drives SIRT1-Dependent Deacetylation Inducing PD-L1 Nuclear Localization in Cervical Cancer.NAD代谢重编程驱动依赖SIRT1的去乙酰化,诱导宫颈癌中PD-L1的核定位。
Adv Sci (Weinh). 2025 Apr;12(15):e2412109. doi: 10.1002/advs.202412109. Epub 2025 Feb 23.
3
Recent Advances in Molecular and Genetic Research on Uveal Melanoma.葡萄膜黑色素瘤的分子遗传学研究进展
Cells. 2024 Jun 12;13(12):1023. doi: 10.3390/cells13121023.
4
PDL1 targeting by miR-138-5p amplifies anti-tumor immunity and Jurkat cells survival in non-small cell lung cancer.miR-138-5p 通过靶向 PD-L1 增强非小细胞肺癌的抗肿瘤免疫和 Jurkat 细胞的存活。
Sci Rep. 2024 Jun 12;14(1):13542. doi: 10.1038/s41598-024-62064-5.
5
Dynamics of Soluble Forms of the Immune Checkpoint Components PD-1/PD-L1/B7-H3, CD314/ULBP1, and HLA-G in Peripheral Blood of Melanoma Patients Receiving Blockers of Programmed Cell Death Protein PD-1.接受程序性细胞死亡蛋白 PD-1 阻滞剂治疗的黑色素瘤患者外周血中免疫检查点成分 PD-1/PD-L1/B7-H3、CD314/ULBP1 和 HLA-G 的可溶性形式的动态变化。
Bull Exp Biol Med. 2023 Aug;175(4):481-486. doi: 10.1007/s10517-023-05891-2. Epub 2023 Sep 29.
6
The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma.免疫检查点 VISTA 与恶性葡萄膜黑色素瘤患者的预后相关。
Front Immunol. 2023 Aug 18;14:1225140. doi: 10.3389/fimmu.2023.1225140. eCollection 2023.
7
Identification of co-expressed gene networks promoting CD8 T cell infiltration and having prognostic value in uveal melanoma.鉴定促进 CD8 T 细胞浸润并具有葡萄膜黑色素瘤预后价值的共表达基因网络。
BMC Ophthalmol. 2023 Aug 10;23(1):354. doi: 10.1186/s12886-023-03098-7.
8
Characterization and Quantitation of the Tumor Microenvironment of Uveal Melanoma.葡萄膜黑色素瘤肿瘤微环境的特征与定量分析
Biology (Basel). 2023 May 19;12(5):738. doi: 10.3390/biology12050738.
9
Nuclear PD-L1 promotes EGR1-mediated angiogenesis and accelerates tumorigenesis.细胞核程序性死亡配体1促进早期生长反应因子1介导的血管生成并加速肿瘤发生。
Cell Discov. 2023 Mar 28;9(1):33. doi: 10.1038/s41421-023-00521-7.
10
Recent Advances and Challenges in Uveal Melanoma Immunotherapy.葡萄膜黑色素瘤免疫治疗的最新进展与挑战
Cancers (Basel). 2022 Jun 23;14(13):3094. doi: 10.3390/cancers14133094.

本文引用的文献

1
Identification of Prognostic Signatures for Predicting the Overall Survival of Uveal Melanoma Patients.用于预测葡萄膜黑色素瘤患者总生存期的预后特征识别
J Cancer. 2019 Aug 27;10(20):4921-4931. doi: 10.7150/jca.30618. eCollection 2019.
2
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?葡萄膜黑色素瘤的免疫基础:免疫治疗是否有理论依据?
Cancers (Basel). 2019 Jul 26;11(8):1055. doi: 10.3390/cancers11081055.
3
Immune Checkpoint Inhibitors in Uveal and Conjunctival Melanoma.葡萄膜和结膜黑色素瘤中的免疫检查点抑制剂
Int Ophthalmol Clin. 2019 Spring;59(2):53-63. doi: 10.1097/IIO.0000000000000263.
4
Computing uveal melanoma basal diameters: a comparative analysis of several novel techniques with improved accuracy.计算葡萄膜黑色素瘤的基底直径:几种具有更高准确性的新技术的对比分析
Int J Retina Vitreous. 2019 Jan 9;5:2. doi: 10.1186/s40942-018-0151-x. eCollection 2019.
5
Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis.肿瘤浸润淋巴细胞在胃癌中的预后作用:一项系统评价和荟萃分析。
Medicine (Baltimore). 2018 Aug;97(32):e11769. doi: 10.1097/MD.0000000000011769.
6
Interferon gamma in cancer immunotherapy.γ干扰素在癌症免疫疗法中的作用。
Cancer Med. 2018 Sep;7(9):4509-4516. doi: 10.1002/cam4.1700. Epub 2018 Jul 23.
7
Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patients.建立过继性细胞疗法用肿瘤浸润淋巴细胞治疗非小细胞肺癌患者。
Cancer Immunol Immunother. 2018 Aug;67(8):1221-1230. doi: 10.1007/s00262-018-2174-4. Epub 2018 May 29.
8
Programmed cell death ligand-1 expression in tumor and immune cells is associated with better patient outcome and decreased tumor-infiltrating lymphocytes in uveal melanoma.肿瘤细胞和免疫细胞程序性死亡配体 1 的表达与葡萄膜黑色素瘤患者更好的预后相关,并与肿瘤浸润淋巴细胞减少相关。
Mod Pathol. 2018 Aug;31(8):1201-1210. doi: 10.1038/s41379-018-0043-5. Epub 2018 Mar 26.
9
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.体内CRISPR筛选确定Ptpn2为癌症免疫治疗靶点。
Nature. 2017 Jul 27;547(7664):413-418. doi: 10.1038/nature23270. Epub 2017 Jul 19.
10
Inflammatory cell infiltrates in advanced metastatic uveal melanoma.晚期转移性葡萄膜黑色素瘤中的炎性细胞浸润。
Hum Pathol. 2017 Aug;66:159-166. doi: 10.1016/j.humpath.2017.06.005. Epub 2017 Jun 24.